{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:02:55Z","timestamp":1772848975694,"version":"3.50.1"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chlamydia infections are frequent causes of respiratory illness, particularly pneumonia in infants, and are linked to permanent reductions in lung function and the induction of asthma. However, the immune responses that protect against early-life infection and the mechanisms that lead to chronic lung disease are incompletely understood. In the current study, we investigated the role of programmed death (PD)-1 and its ligands PD-L1 and PD-L2 in promoting early-life Chlamydia respiratory infection, and infection-induced airway hyperresponsiveness (AHR) and severe allergic airway disease in later life. Infection increased PD-1 and PD-L1, but not PD-L2, mRNA expression in the lung. Flow cytometric analysis of whole lung homogenates identified monocytes, dendritic cells, CD4+, and CD8+ T cells as major sources of PD-1 and PD-L1. Inhibition of PD-1 and PD-L1, but not PD-L2, during infection ablated infection-induced AHR in later life. Given that PD-L1 was the most highly up-regulated and its targeting prevented infection-induced AHR, subsequent analyses focused on this ligand. Inhibition of PD-L1 had no effect on Chlamydia load but suppressed infection-induced pulmonary inflammation. Infection decreased the levels of the IL-13 decoy receptor in the lung, which were restored to baseline levels by inhibition of PD-L1. Finally, inhibition of PD-L1 during infection prevented subsequent infection-induced severe allergic airways disease in later life by decreasing IL-13 levels, Gob-5 expression, mucus production, and AHR. Thus, early-life Chlamydia respiratory infection\u2013induced PD-L1 promotes severe inflammation during infection, permanent reductions in lung function, and the development of more severe allergic airway disease in later life.<\/jats:p>","DOI":"10.1165\/rcmb.2015-0204oc","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T11:59:34Z","timestamp":1442491174000},"page":"493-503","source":"Crossref","is-referenced-by-count":21,"title":["Programmed Death Ligand 1 Promotes Early-Life\n                    <i>Chlamydia<\/i>\n                    Respiratory Infection\u2013Induced Severe Allergic Airway Disease"],"prefix":"10.1093","volume":"54","author":[{"given":"Malcolm R.","family":"Starkey","sequence":"first","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra C.","family":"Brown","sequence":"additional","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ama-Tawiah","family":"Essilfie","sequence":"additional","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Y.","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yagita","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay C.","family":"Horvat","sequence":"additional","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[{"name":"Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"2026021122362149500_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CMR.8.4.451","article-title":"Chlamydia pneumoniae (TWAR)","volume":"8","author":"Kuo","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"2026021122362149500_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.me.43.020192.001533","article-title":"Chlamydia pneumoniae, strain TWAR pneumonia","volume":"43","author":"Grayston","year":"1992","journal-title":"Annu Rev Med"},{"key":"2026021122362149500_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.04.00135703","article-title":"Atypical pathogens and respiratory tract infections","volume":"24","author":"Blasi","year":"2004","journal-title":"Eur Respir J"},{"key":"2026021122362149500_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00006454-198201000-00008","article-title":"Chlamydia trachomatis and chronic respiratory disease in childhood","volume":"1","author":"Harrison","year":"1982","journal-title":"Pediatr Infect Dis"},{"key":"2026021122362149500_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1615\/CritRevImmunol.v29.i4.10","article-title":"Chlamydial infection of immune cells: altered function and implications for disease","volume":"29","author":"Beagley","year":"2009","journal-title":"Crit Rev Immunol"},{"key":"2026021122362149500_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2003.10.007","article-title":"Role of atypical bacterial infection of the lung in predisposition\/protection of asthma","volume":"101","author":"Hansbro","year":"2004","journal-title":"Pharmacol Ther"},{"key":"2026021122362149500_bib7","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.4049\/jimmunol.180.6.4148","article-title":"Endogenous IFN-\u03b3 production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice","volume":"180","author":"Jupelli","year":"2008","journal-title":"J Immunol"},{"key":"2026021122362149500_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/jir.2009.0083","article-title":"The contribution of interleukin-12\/interferon-\u03b3 axis in protection against neonatal pulmonary Chlamydia muridarum challenge","volume":"30","author":"Jupelli","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"2026021122362149500_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/02770900903165582","article-title":"Does Chlamydia pneumoniae infection trigger to development of asthma in wheezy infants?","volume":"46","author":"Zaitsu","year":"2009","journal-title":"J Asthma"},{"key":"2026021122362149500_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1183\/09031936.00019508","article-title":"Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections","volume":"33","author":"Webley","year":"2009","journal-title":"Eur Respir J"},{"key":"2026021122362149500_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1164\/rccm.200407-917OC","article-title":"The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia","volume":"171","author":"Webley","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122362149500_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S2040174412000050","article-title":"Programming of the lung by early-life infection","volume":"3","author":"Hansbro","year":"2012","journal-title":"J Dev Orig Health Dis"},{"key":"2026021122362149500_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1476-5381.2011.01219.x","article-title":"Cytokine\/anti-cytokine therapy - novel treatments for asthma?","volume":"163","author":"Hansbro","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2026021122362149500_bib14","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"2026021122362149500_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1165\/ajrcmb.25.4.4620","article-title":"Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin","volume":"25","author":"Yang","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021122362149500_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"2026021122362149500_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11882-007-0051-x","article-title":"IL-13 receptor isoforms: breaking through the complexity","volume":"7","author":"Tabata","year":"2007","journal-title":"Curr Allergy Asthma Rep"},{"key":"2026021122362149500_bib18","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"Gr\u00fcnig","year":"1998","journal-title":"Science"},{"key":"2026021122362149500_bib19","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.4049\/jimmunol.169.11.6482","article-title":"The role of IL-13 in established allergic airway disease","volume":"169","author":"Taube","year":"2002","journal-title":"J Immunol"},{"key":"2026021122362149500_bib20","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI31546","article-title":"IL-13R\u03b12 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice","volume":"117","author":"Wilson","year":"2007","journal-title":"J Clin Invest"},{"key":"2026021122362149500_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.180.1.522","article-title":"IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung","volume":"180","author":"Zheng","year":"2008","journal-title":"J Immunol"},{"key":"2026021122362149500_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/mi.2013.65","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease","volume":"7","author":"Starkey","year":"2014","journal-title":"Mucosal Immunol"},{"key":"2026021122362149500_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2007.11.002","article-title":"Understanding the mechanisms of viral induced asthma: new therapeutic directions","volume":"117","author":"Hansbro","year":"2008","journal-title":"Pharmacol Ther"},{"key":"2026021122362149500_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1164\/rccm.200607-1005OC","article-title":"Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease","volume":"176","author":"Horvat","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122362149500_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2009.10.018","article-title":"Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology","volume":"125","author":"Horvat","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2026021122362149500_bib26","doi-asserted-by":"crossref","first-page":"e42588","DOI":"10.1371\/journal.pone.0042588","article-title":"Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice","volume":"7","author":"Starkey","year":"2012","journal-title":"PLoS One"},{"key":"2026021122362149500_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mi.2012.99","article-title":"Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease","volume":"6","author":"Starkey","year":"2013","journal-title":"Mucosal Immunol"},{"key":"2026021122362149500_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"2026021122362149500_bib29","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1073\/pnas.0931259100","article-title":"PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells","volume":"100","author":"Loke","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021122362149500_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4049\/jimmunol.1301657","article-title":"PD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis","volume":"192","author":"Fankhauser","year":"2014","journal-title":"J Immunol"},{"key":"2026021122362149500_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mi.2009.112","article-title":"PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions","volume":"3","author":"Akbari","year":"2010","journal-title":"Mucosal Immunol"},{"key":"2026021122362149500_bib32","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaci.2012.09.027","article-title":"Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity","volume":"131","author":"Kerzerho","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2026021122362149500_bib33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/mi.2012.111","article-title":"PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production","volume":"6","author":"Lewkowich","year":"2013","journal-title":"Mucosal Immunol"},{"key":"2026021122362149500_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm.3568","article-title":"Lung microbiota promotes tolerance to allergens in neonates via PD-L1","volume":"20","author":"Gollwitzer","year":"2014","journal-title":"Nat Med"},{"key":"2026021122362149500_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1165\/rcmb.2009-0450OC","article-title":"Essential role of B7-H1 in double-stranded RNA-induced augmentation of an asthma phenotype in mice","volume":"45","author":"Matsumoto","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021122362149500_bib36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1164\/rccm.201501-0188OC","article-title":"Targeting PI3K-p110\u03b1 suppresses influenza virus infection in chronic obstructive pulmonary disease","volume":"191","author":"Chen-Yu Hsu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122362149500_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/thoraxjnl-2014-206067","article-title":"Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma","volume":"70","author":"Essilfie","year":"2015","journal-title":"Thorax"},{"key":"2026021122362149500_bib38","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.0902287","article-title":"Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease","volume":"184","author":"Horvat","year":"2010","journal-title":"J Immunol"},{"key":"2026021122362149500_bib39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/thoraxjnl-2011-200160","article-title":"Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma","volume":"67","author":"Essilfie","year":"2012","journal-title":"Thorax"},{"key":"2026021122362149500_bib40","doi-asserted-by":"crossref","first-page":"e39460","DOI":"10.1371\/journal.pone.0039460","article-title":"TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life","volume":"7","author":"Beckett","year":"2012","journal-title":"PLoS One"},{"key":"2026021122362149500_bib41","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.172.4.2530","article-title":"B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism","volume":"172","author":"Matsumoto","year":"2004","journal-title":"J Immunol"},{"key":"2026021122362149500_bib42","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/eji.200324084","article-title":"Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses","volume":"33","author":"Tsushima","year":"2003","journal-title":"Eur J Immunol"},{"key":"2026021122362149500_bib43","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.4049\/jimmunol.181.10.6707","article-title":"Cutting edge: Programmed death-1\/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy","volume":"181","author":"Chang","year":"2008","journal-title":"J Immunol"},{"key":"2026021122362149500_bib44","doi-asserted-by":"crossref","first-page":"e1002244","DOI":"10.1371\/journal.ppat.1002244","article-title":"Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease","volume":"7","author":"Essilfie","year":"2011","journal-title":"PLoS Pathog"},{"key":"2026021122362149500_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/09031936.00049510","article-title":"Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells","volume":"37","author":"Preston","year":"2011","journal-title":"Eur Respir J"},{"key":"2026021122362149500_bib46","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.4049\/jimmunol.1101299","article-title":"Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells","volume":"188","author":"Thorburn","year":"2012","journal-title":"J Immunol"},{"key":"2026021122362149500_bib47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/thx.2009.131508","article-title":"Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease","volume":"65","author":"Thorburn","year":"2010","journal-title":"Thorax"},{"key":"2026021122362149500_bib48","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.ppat.1001339","article-title":"Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts","volume":"7","author":"Asquith","year":"2011","journal-title":"PLoS Pathog"},{"key":"2026021122362149500_bib49","doi-asserted-by":"crossref","first-page":"18214","DOI":"10.1074\/jbc.M114.548594","article-title":"Importance of mast cell Prss31\/transmembrane tryptase\/tryptase-\u03b3 in lung function and experimental chronic obstructive pulmonary disease and colitis","volume":"289","author":"Hansbro","year":"2014","journal-title":"J Biol Chem"},{"key":"2026021122362149500_bib50","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1016\/j.vaccine.2007.09.034","article-title":"Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae","volume":"25","author":"Preston","year":"2007","journal-title":"Vaccine"},{"key":"2026021122362149500_bib51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaci.2008.06.022","article-title":"Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor \u03b12 in vivo","volume":"122","author":"Chen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2026021122362149500_bib52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/IAI.02764-14","article-title":"Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis","volume":"83","author":"Porcella","year":"2015","journal-title":"Infect Immun"},{"key":"2026021122362149500_bib53","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/labinvest.2011.103","article-title":"Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life","volume":"91","author":"Jupelli","year":"2011","journal-title":"Lab Invest"},{"key":"2026021122362149500_bib54","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4049\/jimmunol.161.5.2317","article-title":"The murine IL-13 receptor \u03b12: molecular cloning, characterization, and comparison with murine IL-13 receptor \u03b11","volume":"161","author":"Donaldson","year":"1998","journal-title":"J Immunol"},{"key":"2026021122362149500_bib55"},{"key":"2026021122362149500_bib56","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4049\/jimmunol.180.4.2225","article-title":"Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity","volume":"180","author":"Kaiko","year":"2008","journal-title":"J Immunol"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/54\/4\/493\/66824202\/ajrcmb_54_4_493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/54\/4\/493\/66824202\/ajrcmb_54_4_493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T03:40:02Z","timestamp":1770867602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/54\/4\/493\/8469772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,1]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2015-0204oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,4]]},"published":{"date-parts":[[2016,4,1]]}}}